Highlights of EuroPCR 2009 –Part I
By Jean Marco & Willam Wijns
Highlights of EuroPCR 2009 –Part II
By Javier Escaned
Discover the new format of EuroPCR 2009 live demonstrations: Live in-a-box. (43 min.)
Here is a case of complex coronary disease in elderly patients who are frequently treated with PCI in routine practice despite the fact they are frequently excluded from clinical trials.
Speaker: J. Fajadet, M. Thomas, D.Tchetche
Opening of EuroPCR 2009 (58 min.)
Speakers: J. Marco, W. Wijns, P.W. Serruys, B. Chevalier, J. Fajadet, D. Taggard, J.F. Robillon
Late breaking trials is always one of the big event of EuroPCR: what’s new this year in both coronary and peripheral field?
Discussion
Speaker: P.W. Serruys
Long term efficacy outcomes following treatment with Zotarolimus-eluting stent: analysis of the pooled Endeavor programme
Speaker: D. Kandzari
Discussion
Speaker: L. Thuesen
Cardioprotective effects of mechanical postconditioning in patients treated with primary PCI evaluated with magnetic resonance
Speaker: T. Engstroem
Discussion
Speaker: F. Weidinger
5-year clinical outcomes after Sirolimus-eluting versus bare metal stent implantation in patients with myocardial infarction
Speaker: C. Penzo
TITAX-Acute myocardial infarction trial: 2-year clinical follow-up
Speaker: P. Karjalainen
4-year follow-up of the TYPHOON study, a randomised trial comparing the Sirolimus-eluting stent to bare metal stents during PCI for acute myocardial infarction
Speaker: C. Spaulding
Discussion
Speaker: M. Sabate
The synergy between PCI with Taxus and cardiac surgery (Syntax) LE MANS study: late (15-month) left main angiographic substudy
Speaker: A.P. Kappetein
Angioslide-Extra angioplasty balloon catheter: the MC-LEADER trial
Speaker: T. Zeller
Zilver ptx clinical trial: 2-year results with polymer-free Paclitaxel coating
Speaker: D. Scheinert





